Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results provide new research routes for scientists trying to detect and beat the disease. Researchers from the Wellcome Trust Centre for Human Genetics participated in this study.
The Medical Sciences Divisional Panel has conferred the title of Professor on ten members of NDM's academic staff, Associate Professor on sixteen members of NDM's academic staff and awarded Dr Geraldine Gillespie the title of University Research Lecturer.
Professor Chris Conlon, Interim Head of Department, attended the First Beijing International Conference on Precision Medicine and Cancer Treatment where he gave a talk on Medical Education in the 21st Century. He highlighted the importance of combining theoretical knowledge and clinical experience and discusssed the impact of sequencing the human genome to medicine. He also discussed some of the problems existing in medical education in different countries.
Professor Dave Stuart's group have studied the structure of the Ebola virus and the effect of two drugs, toremifene and ibruprofen on the virus. The study was the first to solve the unligated structure of the Ebola virus glycoprotein and the results were published in Nature. \r\n\r\nProfessor Stuart told the Independent newspaper: \u201cThis information can guide the design of more powerful anti-Ebola drugs. My group will be continuing this project at Diamond \u2026 which should help us to further accelerate the rational drug design process.\r\n\r\n\"We hope this research will lead to new drugs that can help to save lives if we are faced with further outbreaks of the disease in the future.\u201d
A study by Professor Daniel Lasserson and other members of Oxford University has looked at how out-of-hours GP services are being used to support patients dying at home. The researchers worked with Oxford Health NHS Foundation Trust to look at the use of the GP out-of-hours service for Oxfordshire over four years, finding that at least 1 in every 100 contacts was for palliative \u2013 end-of-life \u2013 care.
An international collaboration between the University of Oxford and other European institutions has uncovered a correlation between a rare mutation in bowel cancers and a better prognosis, raising the possibility that patients with such tumours may not require chemotherapy after surgery. Dr David Church was joint senior author of the study.
The Francis Crick Medal and Lecture is awarded to Professor Simon Myers for transforming our understanding of meiotic recombination and of human population history.
With drug-resistant strains of sexually-transmitted infection gonorrhoea increasing, scientists from Brighton, Oxford University and Public Health England have found that genetic sequencing can track the spread of infection. They show coordinated national and international strategies are required to stop drug-resistance spreading further.
A study by Professor Daniel Lasserson and other members of Oxford University has looked at how out-of-hours GP services are being used to support patients dying at home.
Mucosal Associated Invariant T-cells (MAIT cells) were first identified in 1993 but largely ignored until recently. Australian researchers recently found that they had an important role in fighting bacterial infections.
While HIV is no longer the death sentence it once was, we are yet to defeat it entirely. However, a new study from Oxford University offers hope that HIV will eventually have nowhere to hide
Professor Helen McShane and her team have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new biomarkers which have shown for the first time why immunity from the BCG vaccine is so variable. The biomarkers will also provide valuable clues to assess whether potential new vaccines could be effective.
Results of the trial of the experimental anti-Ebola drug TKM-130803 have been published today. Using a novel approach designed to get rapid indications of a drug's effectiveness, the trial showed that at the dose given the drug did not improve survival compared to historic controls.
The 24 - 30 April is World Immunisation Week with the focus of this year\u2019s WHO campaign is \"Close the immunisation gap\" NDM and Paediatrics spoke to Professor Calman MacLennan, Professor of Vaccine Immunology (University of Birmingham) and Jenner Investigator about how we can \"close the gap\" and get more people vaccinated to prevent deadly diseases.
More than two billion people live in parts of the world where the Zika virus can spread. Detailed maps show that mapping Zika is more complex than simply defining where the mosquito can survive. Dr Oliver Brady from the WTCHG participated in the study.
What is the key to success for women who work in science? A new website delves into the various experiences of successful women scientists at the University of Oxford.
A global network of researchers, coordinated from the Wellcome Trust Centre for Human Genetics in Oxford, carried out a genome-wide association study to identify which genes might be associated with an increased likelihood of developing bacteraemia. Bacteraemia is a bacterial infection of the bloodstream and a major cause of illness and death in sub-Saharan Africa but little is known about whether human genetics play a part.
Oxford spinout company Vaccitech has been launched with \u00a310m seed investment to develop a universal flu vaccine already showing promise in clinical trials.\r\nThe Jenner Institute team is led by Professors Adrian Hill and Sarah Gilbert. Professor Gilbert said: 'Clinical trials of the universal vaccine here in Oxford have shown great promise. The vaccine has proved safe and shown good clinical responses, including enhanced protection against the flu detectable in older adults even one year after vaccination. It has performed well when given with the standard flu vaccine.'
![\"\"](\"https://www.tdi.ox.ac.uk/about/latest-news/research-discoveries-offer-hope-for-managing-ovarian-cancer/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n